Literature DB >> 10401520

Drug-related erectile dysfunction.

L C Keene1, P H Davies.   

Abstract

Erectile dysfunction is a highly prevalent medical problem affecting a significant proportion of men. It is important for a number of reasons, causing impairment of quality of life and, if related to drug therapy, leading to non-compliance. Drug therapy accounts for erectile dysfunction in approximately 25% of cases and is mostly readily reversible when the offending agent is stopped, or a suitable alternative is substituted. Many classes of drug may be responsible, interfering with the normal physiological processes leading to penile erection in a dose-related fashion, and in ways which can usually be predicted from their pharmacology. The most commonly implicated classes of drug include antihypertensives such as thiazide diuretics and beta-adrenoceptor antagonists and psychotherapeutic drugs, especially selective serotonin reuptake inhibitor (SSRI) antidepressants. We review the agents which can cause erectile dysfunction, the evidence for this adverse effect and the physiological mechanisms involved. We present an approach to the management of the patient with erectile dysfunction in whom concomitant drug therapy may be responsible. We recommend that drug therapy should always be considered as a possible cause of erectile dysfunction before specific investigation and therapy is considered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401520

Source DB:  PubMed          Journal:  Adverse Drug React Toxicol Rev        ISSN: 0964-198X


  18 in total

1.  Drugs do not only relieve male menopause.

Authors:  C Hernández-López
Journal:  BMJ       Date:  2000-08-12

Review 2.  Questionnaires to measure sexual quality of life.

Authors:  Renata Arrington; Joseph Cofrancesco; Albert W Wu
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

3.  Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.

Authors:  Arie Roth; Ofra Kalter-Leibovici; Yehuda Kerbis; Ella Tenenbaum-Koren; Juza Chen; Tamar Sobol; Itamar Raz
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 4.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

5.  Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction : meta-analysis of randomised clinical trials.

Authors:  Antònia Agustí; Sara Bonet; Josep Maria Arnau; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  The effect of antihypertensive drugs on erectile function: a proposed management algorithm.

Authors:  Michael Doumas; Stella Douma
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

Review 7.  Sexual function in hypertensive patients receiving treatment.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Vasc Health Risk Manag       Date:  2006

8.  Erectile dysfunction among hypertensive men in a rapidly developing country.

Authors:  Abdulbari Bener; Abdullah Al-Ansari; Mustafa Afifi; Prasad V Krishna
Journal:  Indian J Urol       Date:  2007-04

9.  Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Bo Feng; Xiaochen Yang; Wei Liu; Yongmei Liu; Yun Zhang; Gui Yu; Shengjie Li; Yuqing Zhang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

Review 10.  Rationale for combination therapy as initial treatment for hypertension.

Authors:  Thomas D Giles
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.